CD55 抗体 (AA 35-126)
Quick Overview for CD55 抗体 (AA 35-126) (ABIN7148376)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 35-126
-
交叉反应
- 人
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Human Complement decay-accelerating factor protein (35-126AA)
-
亚型
- IgG
-
-
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 适用: 人 WB, ELISA, PLA 宿主: 小鼠 Monoclonal 1G3 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibodyCD55 适用: 人 WB, ELISA, IHC (fro), ICC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibodyCD55 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibodyCD55 适用: 人 WB, FACS, IHC, IF, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibodyCD55 适用: 人 WB, IF, ELISA 宿主: 小鼠 Monoclonal 1D7 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (Center) antibodyCD55 适用: 人 WB, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibodyCD55 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibodyCD55 适用: 人 WB, IHC, ELISA 宿主: 兔 Monoclonal 1A5 unconjugated Recombinant Antibody
anti-Complement Decay-Accelerating Factor (CD55) antibodyCD55 适用: 人 FACS, IF 宿主: 小鼠 Monoclonal F4-29D9 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 1-381) antibodyCD55 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
-
-
应用备注
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- CD55
-
背景
-
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.
Aliases: CD 55 antibody, CD55 antibody, CD55 antigen antibody, CD55 Cromer blood group system antibody, CD55 Molecule (Cromer blood group) antibody, CD55 Molecule antibody, CD55 Molecule, decay accelerating factor for complement (Cromer blood group) antibody, Cd55a antibody, Complement decay accelerating factor antibody, Complement decay-accelerating factor antibody, Complement decay-accelerating factor, GPI-anchored antibody, CR antibody, CROM antibody, Cromer Blood Group antigen antibody, Cromer blood group system antibody, DAF antibody, Daf-GPI antibody, DAF_HUMAN antibody, Daf1 antibody, Dcay accelerating factor for complement (CD55, Cromer blood group system) antibody, Decay accelarating factor 1, isoform CRA_a antibody, Decay accelerating factor (GPI-form) antibody, Decay Accelerating Factor for Complement antibody, Decay accelerating factor GPI-form antibody, Decay accelerating factor soluble-form antibody, GPI-DAF antibody, TC antibody
-
UniProt
- P08174
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-
